Menveo TM
Listen to the Pronunciation:
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: meningococcal a conjugate vaccine, meningococcal c + meningococcal w135 + meningococcal y conjugate vaccine
Pack: Menveo (1 x MenA vial, 1 x MenCWY vial), 1 pack
Brand name
(ARTG)
: MENVEO meningococcal (Groups A, C, W-135 and Y) oligosaccharide CRM197 conjugate vaccineConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
MENVEO powder and solution for solution for injection (2 vials) MENVEO is indicated for active immunisation of infants and children (from 2 months of age), adolescents and adults to prevent invasive disease caused by Neisseria meningitidis serogroups A, C, W135 and Y. The use of this vaccine should be in accordance with official recommendations.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intramuscular
- White cake
Component :
- Injection, solution
- Intramuscular
- Clear solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Shelf lifetime is 4 Years.
- Store at 2 to 8 degrees Celsius
- Shelf lifetime is 48 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- Multi dose pack 5x MenA Lyo vials / 5x MenCWY vials pack
- single dose pack 1x MenA Lyo vial / 1x MenCWY vial pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems